These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 16039293

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Oral estrogen replacement therapy increases forearm reactive hyperemia accompanied by increases in serum levels of nitric oxide in postmenopausal women.
    Sanada M, Higashi Y, Nakagawa K, Sasaki S, Kodama I, Sakashita T, Tsuda M, Ohama K.
    Gynecol Endocrinol; 2001 Apr; 15(2):150-7. PubMed ID: 11379012
    [Abstract] [Full Text] [Related]

  • 25. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M, Fait T, Kovar J, Poledne R, Ceska R.
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.
    Cakal E, Turgut AT, Demirbas B, Ozkaya M, Cakal B, Serter R, Aral Y.
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):294-300. PubMed ID: 19085705
    [Abstract] [Full Text] [Related]

  • 32. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Christodoulakos GE, Lambrinoudaki IV, Economou EV, Papadias C, Vitoratos N, Panoulis CP, Kouskouni EE, Vlachou SA, Creatsas GC.
    Atherosclerosis; 2007 Jul; 193(1):142-50. PubMed ID: 16842799
    [Abstract] [Full Text] [Related]

  • 33. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study.
    Hemelaar M, van der Mooren MJ, Mijatovic V, Bouman AA, Schijf CP, Kroeks MV, Franke HR, Kenemans P.
    Menopause; 2003 Jul; 10(6):550-8. PubMed ID: 14627865
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Lipids and antioxidative effects of estradiol and sequential norethisterone acetate treatment in a 3-month randomized controlled trial.
    Falkeborn M, Lithell H, Persson I, Vessby B, Naessén T.
    Climacteric; 2002 Sep; 5(3):240-8. PubMed ID: 12419082
    [Abstract] [Full Text] [Related]

  • 38. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S, Boermans AJ.
    Osteoporos Int; 2002 Sep; 13(2):176-83. PubMed ID: 11908492
    [Abstract] [Full Text] [Related]

  • 39. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M, Theppisai U, Manonai J, Suchartwatnachai C, Jorgensen LN.
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [Abstract] [Full Text] [Related]

  • 40. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women.
    Best PJ, Berger PB, Miller VM, Lerman A.
    Ann Intern Med; 1998 Feb 15; 128(4):285-8. PubMed ID: 9471931
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.